Latest news
The Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2 - fiercepharma.comfiercepharma.com · Sat, 08 Aug 2026 09:32:14 GMTPfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 19:48:00 GMTOrforglipron vs. Tirzepatide: What Are the Major Differences? - GoodRxGoodRx · Fri, 07 Aug 2026 16:36:16 GMTLilly, Novo defeat antitrust lawsuit over GLP‑1 drug market - ReutersReuters · Thu, 06 Aug 2026 21:52:51 GMTEli Lilly Surpasses Wall Street Estimates on Injectable GLP-1 Drugs - Pharmaceutical ExecutivePharmaceutical Executive · Thu, 06 Aug 2026 14:12:46 GMTAmazon Pharmacy delivering $50 GLP-1s to Medicare seniors via Bridge Program - Drug Store NewsDrug Store News · Thu, 06 Aug 2026 13:37:52 GMTLilly beats forecasts as Mounjaro, Zepbound drive 48% revenue surge - The Pharma LetterThe Pharma Letter · Thu, 06 Aug 2026 11:50:30 GMTAmazon Pharmacy now delivers GLP-1 medications to eligible Medicare patients for $50 a month - About AmazonAbout Amazon · Thu, 06 Aug 2026 10:07:15 GMT